Which segment accounted for the largest North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market share?

The largest market share is held by the hospitals segment, as these facilities are primary centers for cardiac diagnosis and device implantations. Hospitals benefit from higher patient influx, availability of advanced equipment, and skilled professionals, making them the leading application in this market.

Home Healthcare

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Q: Who are the key players in North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market industry?

The top five key players are Medtronic, Abbott Laboratories, Boston Scientific Corporation, GE Healthcare, and Philips Healthcare. These companies dominate the market by offering wide portfolios of advanced cardiac monitoring and rhythm management devices, robust R&D capabilities, and strong distribution networks across North America.

Q: What is the North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market growth?

The North America market has shown strong growth, driven by the rising prevalence of cardiac disorders and technological advancements. In 2023, Abbott reported significant growth in its cardiac rhythm management segment, propelled by increased adoption of remote monitoring solutions and implantable cardiac devices.

Q: What are the factors driving the North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market?

Key drivers include growing incidence of cardiovascular diseases, increased use of remote monitoring technology, and favorable reimbursement policies. For example, Medtronic has introduced wireless cardiac monitors that promote early diagnosis and efficient patient management, fostering substantial market growth.

Q: Which type accounted for the largest North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market share?

Implantable Cardioverter Defibrillators (ICDs) accounted for the largest market share by type. Their high adoption is due to proven effectiveness in reducing sudden cardiac deaths, technological advancements, and increasing recommendations by healthcare professionals in North America.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market: by Type (ECG Devices, Implantable Loop Recorders, Cardiac Output Monitoring Devices, Mobile Cardiac Telemetry Devices, Pacemakers, Defibrillators), Application (Arrhythmias, Heart Failure, Myocardial Infarction, Syncope, Congenital Heart Disease, Others), Distribution Channels (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Online Sales, Others), Technology (Wireless, Wired, AI-based Monitoring, Remote Monitoring, Cloud-based Solutions, Conventional Monitoring), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20449

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Comprehensive Study (2020-2035)

The North America Cardiac Monitoring & Cardiac Rhythm Management Devices market is experiencing a robust expansion driven by technological advancements, a rising burden of cardiovascular diseases, and evolving patient care models across the region. As demand for continuous cardiac monitoring rises, adoption of next-generation devices, including AI-based and remote monitoring solutions, continues to increase, transforming care delivery and improving patient outcomes. The market is segmented by device type, application, distribution channels, technology, and organization size, with the United States holding the largest market share, followed by Canada and Mexico. Key players such as Medtronic, Abbott, and Boston Scientific are focusing on innovation and strategic partnerships to maintain competitiveness. The outlook for 2025-2035 remains promising with significant opportunities in home care, digital health integration, and personalized patient solutions.

Latest Market Dynamics

Key Drivers

Growing prevalence of cardiovascular diseases in North America, fueled by unhealthy lifestyles and an aging population. For example,

reported increasing demand for their mobile cardiac telemetry devices in 2024 due to higher arrhythmia detection rates.

Advancements in AI-based monitoring technologies that enhance early diagnosis and remote patient management, exemplified by Medtronic’s expanded rollout of their AI-enabled cardiac rhythm management platform in early 2025.

Integrated remote monitoring becoming mainstream, with cloud-based solutions enabling real-time patient data access—Philips Healthcare launched cloud-connected ECG platforms in Q3 2024.
Increasing adoption of wearable and mobile cardiac telemetry devices, as seen with GE Healthcare’s expanded partnership with digital health providers in late 2024.

Key Opportunities

Growing demand for home-based cardiac care solutions, spurred by consumer interest in telehealth—Boston Scientific’s launch of home-monitoring pacemaker technologies in 2024 demonstrates this trend.
Investment in AI-driven predictive analytics to improve clinical interventions, with Siemens Healthineers unveiling predictive cardiac risk platforms in Q4 2024.

Complex regulatory environment hindering rapid product approvals, as experienced by LivaNova PLC in their delayed 2024 implantable device launch.
Interoperability concerns between legacy systems and new monitoring technologies, highlighted by issues raised during Nihon Kohden’s device integration trials across U.S. hospitals in 2024.

Data privacy and security concerns with cloud-based and remote monitoring solutions, a challenge recently addressed by Boston Scientific with additional cybersecurity features in 2024.
High cost of advanced cardiac rhythm management devices potentially limiting adoption by smaller healthcare facilities, reported as a barrier by multiple ambulatory care centers surveyed in 2024.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Share by Type, 2025 (%)

In 2025, the North American market is led by ECG Devices and Pacemakers, underscoring ongoing demand for continuous monitoring and rhythm management technologies. Defibrillators and implantable loop recorders also command significant shares, propelled by technological improvements and broader clinical applications. Cardiac output monitoring and mobile cardiac telemetry devices are rapidly gaining adoption, particularly in ambulatory and home care settings. This distribution reflects the region’s emphasis on early intervention and patient safety, with market leaders focusing on both hospital and at-home solutions.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Share by Application, 2025 (%)

The major application for cardiac monitoring and rhythm management devices in North America is Arrhythmias, reflecting a high prevalence and effective management pipeline. Heart Failure ranks second, driven by an aging population and chronic disease prevalence. Myocardial Infarction and Syncope represent notable shares, attributed to rising incidences and improved diagnostic capabilities. Congenital Heart Disease and other niche applications continue to grow as awareness and screening rates increase, reinforcing the need for diverse device portfolios.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Revenue (USD Million), 2020-2035

From 2020 to 2035, the North American cardiac monitoring and cardiac rhythm management devices market is forecasted to grow significantly, as revenue is projected to increase from 7,820 million USD in 2021 to 17,940 million USD by 2035. The market is bolstered by technological innovations, increased adoption of remote and home care monitoring, and strategic investments by key industry players. The trend reflects both an expanding patient base and advancements in device capabilities that support both acute and chronic cardiovascular management.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market YOY Growth (%), 2020-2035

Year-over-year growth for the cardiac monitoring and rhythm management devices market in North America exhibits consistent positive momentum between 2020 and 2035. The YOY rate fluctuates slightly, peaking during years where major technology launches and digital health integrations occur. For example, growth is estimated at 8.2% in 2025 and moderates to 6.1% by 2035 as the market matures. This reflects sustained investment in innovation and ongoing demand for cardiovascular care management.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Share by Country, 2025 (%)

The United States dominates the North American market for cardiac monitoring and rhythm management devices in 2025, accounting for the lion’s share of total revenue, reflective of advanced healthcare infrastructure and greater patient awareness. Canada has a notable share, driven by rising adoption of digital health and strong governmental support for cardiac care. Mexico, while representing a smaller portion, is witnessing rapid growth due to improving healthcare access and awareness campaigns for cardiac health.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Player Share (%), 2025

Medtronic, Abbott Laboratories, and Boston Scientific Corporation are leading players in North America's cardiac monitoring and rhythm management devices market, collectively accounting for over 60% market share. These companies leverage broad portfolios, continuous innovation, and strong distribution networks to maintain their leadership. GE Healthcare and Philips Healthcare also hold significant shares through their comprehensive cardiac care offerings and strategic partnerships. The remainder of the market is split among emerging players and specialized device manufacturers.

North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Buyer Share (%), 2025

Hospitals are the primary buyers of cardiac monitoring and rhythm management devices in North America, driven by high procedural volumes and advanced cardiac care infrastructure. Clinics and ambulatory surgical centers are also significant buyers, with growing roles in elective and outpatient cardiac services. The rise of home care settings and increased adoption via online sales platforms reflect shifting care models and patient empowerment trends, further diversifying the buyer landscape.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	9870
Regions	US, Canada, Mexico
Segments	By Type (ECG Devices, Implantable Loop Recorders, Cardiac Output Monitoring Devices, Mobile Cardiac Telemetry Devices, Pacemakers, Defibrillators), By Application (Arrhythmias, Heart Failure, Myocardial Infarction, Syncope, Congenital Heart Disease, Others), By Distribution Channels (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Online Sales, Others), By Technology (Wireless, Wired, AI-based Monitoring, Remote Monitoring, Cloud-based Solutions, Conventional Monitoring), By Organization Size (Small, Medium, Large)
Players	Medtronic, Abbott Laboratories, Boston Scientific Corporation, GE Healthcare, Philips Healthcare, Siemens Healthineers, Biotronik, Hill-Rom Holdings, Cardiac Science Corporation, LivaNova PLC, MicroPort Scientific, Nihon Kohden Corporation, Schiller AG, Fukuda Denshi, Mortara Instrument

Key Recent Developments

In July 2024, Medtronic announced the FDA approval of its AI-powered cardiac rhythm management platform, targeting improved early intervention.
In June 2024, Boston Scientific launched a home-based remote pacemaker monitoring solution, enhancing virtual care capabilities.
In August 2024, Philips Healthcare partnered with a leading digital health network in Canada to advance its cloud-based ECG solution.
In July 2024, Siemens Healthineers unveiled a next-generation predictive analytics tool for cardiac risk assessment.
In June 2024, Abbott received expanded reimbursement for its mobile cardiac telemetry devices in the US following clinical outcome improvements.

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates